Literature DB >> 7925478

Role of actin in platelet function.

P Lefebvre1, J G White, M D Krumwiede, I Cohen.   

Abstract

Cytochalasin E (CE) was used in this study to evaluate relationships between platelet shape change, pseudopod extension, internal transformation, actin filament assembly, fibrinogen receptor expression, aggregation, clot tension and secretion. Various ratios of G- to F-actin, measured by the DNase inhibition assay, were achieved by using several concentrations of CE in stirred and unstirred thrombin-stimulated platelets. An increased rate of actin polymerization was found in "aggregating" conditions as compared to "activating" conditions, the latter achieved by either absence of stirring or stirring in the presence of the tetrapeptide Arg-Gly-Asp-Ser (RGDS). Larger concentrations of CE were required in aggregated than in activated platelets to obtain G-actin levels analogous to those in resting platelets. Concentrations of polymerizing actin above 20% and 55% for activated and aggregated platelets, respectively, trigger platelet shape change and the extension of pseudopods. Prevention of de novo actin polymerization by CE, added either before or after thrombin stimulation, inhibits fibrinogen binding to platelets. This suggests an involvement of the new actin polymers in fibrinogen receptor exposure. As expected, platelet aggregation and clot tension, which are dependent on fibrinogen receptor exposure, were inhibited by CE. Granular secretion was not dependent on polymerizing actin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7925478

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

1.  Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin.

Authors:  Maribel Díaz-Ricart; Gemma Arderiu; Eva Estebanell; Silvia Pérez-Pujol; Miguel Lozano; James G White; Ginés Escolar; Antonio Ordinas
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.

Authors:  Gabriella Passacquale; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

3.  Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.

Authors:  K Holmbäck; M J Danton; T T Suh; C C Daugherty; J L Degen
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

4.  High-throughput platelet spreading analysis: a tool for the diagnosis of platelet-based bleeding disorders.

Authors:  Abdullah O Khan; Annabel Maclachlan; Gillian C Lowe; Phillip L R Nicolson; Rashid Al Ghaithi; Steven G Thomas; Steve P Watson; Jeremy A Pike; Neil V Morgan
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

Review 5.  Platelet Shape Changes and Cytoskeleton Dynamics as Novel Therapeutic Targets for Anti-Thrombotic Drugs.

Authors:  Eun-Kyung Shin; Hanseul Park; Ji-Yoon Noh; Kyung-Min Lim; Jin-Ho Chung
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

6.  Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.

Authors:  Benjamin Aj Reddi; Samantha M Iannella; Stephanie N O'Connor; Adam M Deane; Scott R Willoughby; David P Wilson
Journal:  Intensive Care Med Exp       Date:  2015-02-12

7.  Wdr1-Dependent Actin Reorganization in Platelet Activation.

Authors:  Swapan K Dasgupta; Anhquyen Le; Qi Da; Miguel Cruz; Rolando E Rumbaut; Perumal Thiagarajan
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.